Back to DMYD-B.STView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Latent Autoimmune Diabetes in Adults
View Full LandscapeDrug Information
Target Indication
Latent Autoimmune Diabetes in Adults
Clinical Trial
NCT04262479Last updated: 8/15/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®Phase 3
Type 1 Diabetes Mellitus
rhGAD65 formulated in Alhydrogel® (Diamyd®)Phase 2
Latent Autoimmune Diabetes in Adult (LADA)
NP2Phase 2
Intractable Pain
DiamydPhase 2
Diabetes Mellitus, Type 1
GAD-AlumPhase 2
Diabetes Mellitus, Type 1
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts